Agios Pharmaceuticals, Inc. (AGIO)
NASDAQ: AGIO · Real-Time Price · USD
35.22
+1.47 (4.36%)
Feb 21, 2025, 4:00 PM EST - Market closed
Agios Pharmaceuticals Cash Flow Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2019 - 2015 |
|---|---|---|---|---|---|---|
Period Ending | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2019 - 2015 |
| Net Income | 673.73 | -352.09 | -231.8 | 1,605 | -327.37 | Upgrade
|
| Depreciation & Amortization | 5.65 | 6.62 | 8.56 | 9.24 | 9.79 | Upgrade
|
| Loss (Gain) From Sale of Assets | -200.04 | 0.55 | -0.05 | 0.01 | - | Upgrade
|
| Loss (Gain) From Sale of Investments | -14.65 | -5.08 | -1.2 | 6.95 | 3.02 | Upgrade
|
| Stock-Based Compensation | 42.85 | 44.77 | 49.3 | 53.51 | 61.6 | Upgrade
|
| Other Operating Activities | -877.61 | 28.22 | -117.86 | -1,952 | 7.05 | Upgrade
|
| Change in Accounts Receivable | -1.3 | -0.6 | -2.21 | - | - | Upgrade
|
| Change in Inventory | -8.54 | -10.58 | -8.49 | - | - | Upgrade
|
| Change in Accounts Payable | 6.6 | -8.73 | 3.44 | 1.86 | 3.33 | Upgrade
|
| Change in Income Taxes | 0.87 | - | - | - | - | Upgrade
|
| Change in Other Net Operating Assets | -17.4 | 0.86 | -9.17 | -38.69 | -1.37 | Upgrade
|
| Operating Cash Flow | -389.84 | -296.06 | -309.48 | -407.32 | -290.76 | Upgrade
|
| Capital Expenditures | -1.69 | -1 | -4.88 | -5.74 | -14.11 | Upgrade
|
| Sale of Property, Plant & Equipment | 0.04 | 1.33 | 0.96 | - | - | Upgrade
|
| Divestitures | 200 | - | - | - | - | Upgrade
|
| Sale (Purchase) of Intangibles | - | -17.5 | - | - | - | Upgrade
|
| Investment in Securities | -724.05 | 256.75 | 115.39 | -548.42 | 90.66 | Upgrade
|
| Other Investing Activities | 889.14 | - | 131.78 | 1,803 | -0.8 | Upgrade
|
| Investing Cash Flow | 363.44 | 239.58 | 243.26 | 1,249 | 75.75 | Upgrade
|
| Long-Term Debt Repaid | - | - | -0.33 | -0.58 | -0.34 | Upgrade
|
| Net Debt Issued (Repaid) | - | - | -0.33 | -0.58 | -0.34 | Upgrade
|
| Issuance of Common Stock | 14.44 | 5.43 | 2.68 | 37.3 | 11.32 | Upgrade
|
| Repurchase of Common Stock | - | - | - | -802.49 | - | Upgrade
|
| Other Financing Activities | - | - | - | - | 250.54 | Upgrade
|
| Financing Cash Flow | 14.44 | 5.43 | 2.35 | -765.77 | 261.52 | Upgrade
|
| Net Cash Flow | -11.96 | -51.05 | -63.87 | 75.69 | 46.51 | Upgrade
|
| Free Cash Flow | -391.53 | -297.06 | -314.36 | -413.06 | -304.87 | Upgrade
|
| Free Cash Flow Margin | -1072.73% | -1107.49% | -2207.58% | - | - | Upgrade
|
| Free Cash Flow Per Share | -6.76 | -5.34 | -5.74 | -6.83 | -4.42 | Upgrade
|
| Cash Income Tax Paid | 43.15 | 1.57 | - | 16.08 | - | Upgrade
|
| Levered Free Cash Flow | -222.83 | -215.06 | -195.32 | -198.29 | -168.57 | Upgrade
|
| Unlevered Free Cash Flow | -222.83 | -215.06 | -195.32 | -198.29 | -168.57 | Upgrade
|
| Change in Net Working Capital | 3.56 | 3.27 | 5.14 | 18.78 | 15.91 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.